Latest AI and machine learning research in dementia for healthcare professionals.
Interventions targeting social and health-related risk factors are thought to reduce the risk of cognitive decline and dementia in older age. Despite well-known social, economic, and cultural differences across European countries, little is known about how these factors influence associations with memory function in different geographical contexts. This study examined the relationship between five...
Whether individual-level cognitive trajectories in Parkinson's disease are predictable remains unresolved. Here, we provide convergent evidence that measurement fidelity, rather than model complexity, governs the prediction ceiling. We evaluated ten machine learning paradigm families across 26 configurations in two independent cohorts-the Parkinson's Progression Markers Initiative (PPMI, N = 1018)...
BACKGROUND: Early identification of autism spectrum disorder (ASD) is essential for improving developmental outcomes but remains challenging due to di...
Early detection and biological characterization of Alzheimer's disease (AD) remain challenging, as current diagnostic approaches rely on invasive cere...
Semi-quantitative positron emission tomography (PET) analysis, particularly Centiloid and CenTauRz scaling, is essential for Alzheimer's disease (AD) ...
Artificial Intelligence (AI) has become integral to the research of neurological diseases due to the rapid expansion of neuroimaging, clinical, physio...
BACKGROUND: Dementia caregiving entails chronic, fluctuating stress with downstream risks to caregivers' mental health and quality of care. Mindfulnes...
OBJECTIVE: This study uses bibliometric analysis and knowledge mapping methods to systematically explore the emerging research frontiers and developme...
As a progressive neurodegenerative disorder, Alzheimer's disease (AD) requires early and accurate diagnosis to delay pathological progression and impr...
Neurodegenerative diseases, such as Mild Cognitive Impairment (MCI) and Alzheimer's, pose significant challenges due to their progressive nature and l...
BACKGROUND: In an attempt to overcome the space-time limitations of traditional training we used a new telemedicine home-training model (Videotraining...
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are described as a disease continuum, given their shared clinical, genetic and p...
BackgroundAlzheimer's disease (AD) lacks effective disease-modifying therapies and scalable, ecologically valid biomarkers to monitor treatment respon...
BackgroundAlzheimer's disease (AD) is the most common cause of dementia whose prevalence is projected to increase significantly in the coming decades....
Human languages are unique in their capacity to tell stories. Prior neuroimaging studies show that spoken language narrative comprehension engages a n...
BackgroundNeuropsychiatric symptoms (NPS) are common in Alzheimer's disease (AD) and mild cognitive impairment (MCI), yet their detection relies on su...
Accurate quantification of structurally similar metabolites as biomarkers in biofluids has remained a longstanding challenge. Here, we report a semico...
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized by complex molecular alterations across multiple brain regions. ...
OBJECTIVE: High accuracy in medical classification tasks does not ensure that neural networks reason in ways consistent with clinical or neurobiologic...
Microglial cells are key players in maintaining brain homeostasis and responding to pathological conditions. Their multifaceted roles in health and di...